UK markets closed
NIKKEI 225
38,202.37 -632.73 (-1.63%) HANG SENG
18,313.86 -165.51 (-0.90%) CRUDE OIL
79.19 +0.81 (+1.03%) GOLD FUTURES
2,317.80 -6.40 (-0.28%) DOW
39,062.10 +177.84 (+0.46%) Bitcoin GBP
49,745.47 -773.57 (-1.53%)
Harvard Bioscience, Inc. (HBIO)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 03:38PM EDT. Market open.
| Previous close | 3.7500 |
| Open | 3.6500 |
| Bid | 3.6600 x 100 |
| Ask | 3.7000 x 100 |
| Day's range | 3.6500 - 3.8700 |
| 52-week range | 3.4400 - 6.2000 |
| Volume | |
| Avg. volume | 92,480 |
| Market cap | 160.659M |
| Beta (5Y monthly) | 1.45 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q1 2024 Earnings Call Transcript
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q1 2024 Earnings Call Transcript May 7, 2024 Harvard Bioscience, Inc. misses on earnings expectations. Reported EPS is $-0.10815 EPS, expectations were $0.02. Harvard Bioscience, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, […]
- GuruFocus.com
Harvard Bioscience Inc (HBIO) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...
Despite a revenue dip, HBIO maintains robust margins and advances strategic initiatives to bolster future growth.
- GuruFocus.com
Harvard Bioscience Inc (HBIO) Q1 2024 Earnings: Challenges Persist Amidst Strategic Adjustments
First Quarter Reveals Revenue Decline and Net Loss, Despite Strong Gross Margin
© 2024 Yahoo. All rights reserved.